Literature DB >> 16118536

Mild cognitive impairment: where are we?

Ronald C Petersen1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16118536     DOI： 10.1097/01.wad.0000179417.95584.90

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN： 0893-0341            Impact factor:   2.703


× No keyword cloud information.
  5 in total

Review 1.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

2.  MEG spectral analysis in subtypes of mild cognitive impairment.

Authors:  M E López; P Cuesta; P Garcés; P N Castellanos; S Aurtenetxe; R Bajo; A Marcos; M L Delgado; P Montejo; J L López-Pantoja; F Maestú; A Fernandez
Journal:  Age (Dordr)       Date:  2014-02-16

3.  Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.

Authors:  Gregory H Pelton; Oliver L Harper; Matthias H Tabert; Harold A Sackeim; Nikolaos Scarmeas; Steven P Roose; D P Devanand
Journal:  Int J Geriatr Psychiatry       Date:  2008-07       Impact factor: 3.485

4.  Diagnostic accuracy of early cognitive indicators in mild cognitive impairment.

Authors:  Marina Martorelli; Larissa Hartle; Gabriel Coutinho; Daniel Correa Mograbi; Daniel Chaves; Claudia Silberman; Helenice Charchat-Fichman
Journal:  Dement Neuropsychol       Date:  2020-12

5.  Examination of Variables That May Affect the Relationship Between Cognition and Functional Status in Individuals with Mild Cognitive Impairment: A Meta-Analysis.

Authors:  Courtney Mcalister; Maureen Schmitter-Edgecombe; Richard Lamb
Journal:  Arch Clin Neuropsychol       Date:  2016-01-06       Impact factor: 2.813
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.